Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bull Exp Biol Med ; 169(1): 89-94, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32500229

RESUMO

The effects of the newly synthesized covalent conjugates of water-soluble fullerene derivatives (WSFD) with xanthene dyes: polyanionic WSFD-fluorescein (1), polycationic WSFD-fluorescein (2), polyanionic WSFD-eosin (3), and polyanionic WSFD (4), polycationic WSFD (5), fluorescein (6) and eosin (7), on activity of the membrane-bound Ca2+-ATPase of the sarcoplasmic reticulum (SR Ca2+-ATPase) were studied. Compounds 1, 3, 4, 6, and 7 inhibit the hydrolytic function of the enzyme, the inhibition constants for these compounds are Ki=1.3×10-5 M (1), Ki=4.7×10-6 M (3), Ki=2.5×10-6 M (4), Ki=6.1×10-5 M (6), and Ki=5.8×10-6 M (7). The effects of compounds 3, 6, and 7 on the hydrolytic function of the enzyme is competitive; compounds 1 and 4 are noncompetitive. Polycationic WSFD fluorescein (2) and polycationic WSFD (5) do not affect ATP hydrolysis, but inhibit active Ca2+ transport in a concentration of 0.01 mM by 100±10 and 40±4%, respectively. Conjugates 1 and 3 completely inhibit the hydrolytic and transport functions of the enzyme in a concentration of 0.01 mM, and in a concentration of 0.001 mM inhibit active Ca2+ transport by 60±6 and 55±6% uncoupling the hydrolytic and transport functions of SR Ca2+-ATPases. The obtained results demonstrate a significant effect of the studied compounds on the active transmembrane transfer of Ca2+ and make it possible to predict the presence of antimetastatic and antiaggregatory activities of the studied compounds.


Assuntos
ATPases Transportadoras de Cálcio/efeitos dos fármacos , Fulerenos/farmacologia , Retículo Sarcoplasmático/enzimologia , Xantenos/farmacologia , Animais , Cálcio/metabolismo , ATPases Transportadoras de Cálcio/antagonistas & inibidores , ATPases Transportadoras de Cálcio/metabolismo , Corantes/química , Corantes/farmacologia , Fulerenos/química , Humanos , Cinética , Ligação Proteica/efeitos dos fármacos , Retículo Sarcoplasmático/efeitos dos fármacos , Retículo Sarcoplasmático/metabolismo , Xantenos/química
2.
Dokl Biochem Biophys ; 488(1): 320-323, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31768851

RESUMO

It was shown for the first time that pentaamino acid derivative of fullerene C60 (potassium salt of fullerenylpenta-N-dihydroxytyrosine) affects three targets of type 2 diabetes mellitus. It competitively inhibits the enzymes aldose reductase and sorbitol dehydrogenase and also has an antiglycation effect on bovine serum albumin. The inhibition constants for these enzymes were calculated.


Assuntos
Aldeído Redutase/química , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Hipoglicemiantes/química , L-Iditol 2-Desidrogenase/química , Aldeído Redutase/metabolismo , Animais , Avaliação Pré-Clínica de Medicamentos , L-Iditol 2-Desidrogenase/metabolismo , Camundongos
3.
Bull Exp Biol Med ; 163(3): 321-325, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28744631

RESUMO

We studied the effects of new water-soluble polysubstituted fullerene C60 (PFD) derivatives on activity of Ca2+-Mg2+ ATPase of the sarcoplasmic reticulum and cGMP phosphodiesterase. All examined fullerene derivatives inhibited activity of both enzymes. For instance, PFD-I, PFD-II, PFD-III, PFD-V, PFD-IX, PFD-X, and PFD-XI in a concentration of 5×10-5 M completely inhibited hydrolytic and transport functions of Ca2+-ATPase. These compounds in a concentration of 5×10-6 suppressed active transport of calcium ions by 51±5, 77±8, 52±5, 52±5, 100±10, 80±8, and 100±10%, respectively, and inhibited ATP hydrolysis by 31±3, 78±8, 18±2, 29±3, 78±8, 63±7, and 73±9%, respectively, uncoupling the hydrolytic and transport functions of the enzyme. PFD-I noncompetitive and reversibly reduced activity of Ca2+-ATPase (Ki=2.3×10-6 M). All the studied fullerene derivatives (except for PFD-VII) inhibited cGMP phosphodiesterase by more than 80% in concentration of 10-4 M and higher and by more than 50% in concentration of 10-5 M. PFD-I is a non-competitive reversible inhibitor of cGMP phosphodiesterase (Ki=7×10-6 M). These results allow us to expect antimetastatic, antiaggregatory, antihypertensive and vasodilative activity of the studied compounds.


Assuntos
ATPase de Ca(2+) e Mg(2+)/antagonistas & inibidores , Cálcio/metabolismo , Nucleotídeo Cíclico Fosfodiesterase do Tipo 6/antagonistas & inibidores , Fulerenos/farmacologia , Retículo Sarcoplasmático/efeitos dos fármacos , Trifosfato de Adenosina/metabolismo , Animais , Transporte Biológico Ativo/efeitos dos fármacos , ATPase de Ca(2+) e Mg(2+)/isolamento & purificação , ATPase de Ca(2+) e Mg(2+)/metabolismo , Nucleotídeo Cíclico Fosfodiesterase do Tipo 6/isolamento & purificação , Nucleotídeo Cíclico Fosfodiesterase do Tipo 6/metabolismo , Fulerenos/química , Hidrólise , Transporte de Íons/efeitos dos fármacos , Cinética , Músculo Esquelético/química , Coelhos , Retículo Sarcoplasmático/química , Retículo Sarcoplasmático/enzimologia
4.
Oxid Med Cell Longev ; 2016: 9895245, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27635190

RESUMO

The influence of a water-soluble [60] fullerene derivative containing five residues of 3-phenylpropionic acid and a chlorine addend appended to the carbon cage (F-828) on serum-starving human embryo lung diploid fibroblasts (HELFs) was studied. Serum deprivation evokes oxidative stress in HELFs. Cultivation of serum-starving HELFs in the presence of 0.1-1 µM F-828 significantly decreases the level of free radicals, inhibits autophagy, and represses expression of NOX4 and NRF2 proteins. The activity of NF-κB substantially grows up in contrast to the suppressed NRF2 activity. In the presence of 0.2-0.25 µM F-828, the DSB rate and apoptosis level dramatically decrease. The maximum increase of proliferative activity of the HELFs and maximum activity of NF-κB are observed at these concentration values. Conclusion. Under the conditions of oxidative stress evoked by serum deprivation the water-soluble fullerene derivative F-828 used in concentrations of 0.1 to 1 µM strongly stimulates the NF-κB activity and represses the NRF2 activity in HELFs.


Assuntos
Fulerenos/farmacologia , NF-kappa B/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Autofagia/efeitos dos fármacos , Pontos de Checagem do Ciclo Celular , Membrana Celular/metabolismo , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Meios de Cultura Livres de Soro/farmacologia , Diploide , Endocitose/efeitos dos fármacos , Fibroblastos/citologia , Radicais Livres/metabolismo , Humanos , Pulmão/citologia , Microscopia de Fluorescência , NADPH Oxidase 4 , NADPH Oxidases/genética , NADPH Oxidases/metabolismo , Fator 2 Relacionado a NF-E2/metabolismo
5.
Artigo em Inglês | MEDLINE | ID: mdl-27402482

RESUMO

Water-soluble fullerenes have been studied as potential nanovectors and therapeutic agents, but their possible toxicity is of concern. We have studied the effects of F-828, a soluble fullerene [C60] derivative, on diploid human embryonic lung fibroblasts (HELFs) in vitro. F-828 causes complex time-dependent changes in ROS levels. Inhibition of Nox4 activity by plumbagin blocks F-828-dependent ROS elevation. F-828 induces DNA breaks, as measured by the comet assay and γH2AX expression, and the activities of the transcription factors NF-kB and p53 increase. F-828 concentrations>25µM are cytotoxic; cell death occurs by necrosis. Expression levels of TGF-ß, RHOA, RHOC, ROCK1, and SMAD2 increase following exposure to F-828. Our results raise the possibility that fullerene F-828 may induce pulmonary fibrosis in vivo.


Assuntos
DNA/genética , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Fulerenos/toxicidade , Pulmão/citologia , Linhagem Celular , Ensaio Cometa , DNA/efeitos dos fármacos , Quebras de DNA/efeitos dos fármacos , Fulerenos/química , Humanos , Espécies Reativas de Oxigênio/metabolismo
6.
Biofizika ; 60(1): 38-43, 2015.
Artigo em Russo | MEDLINE | ID: mdl-25868339

RESUMO

In this work, we investigated the effect of dilution on aggregation of nanoparticles of the polycarboxylic derivative of fullerene C60. It is shown that the diminution of the concentration of PCDF-1 in aqueous medium leads to a decreased amount of aggregates of fullerene and an increased amount of single molecules. This can potentially interfere with the biological activity of a compound on one molecule basis. Addition of organic and inorganic salts to the aqueous medium with fullerene derivative leads to intense disaggregation of PCDF-1. The data obtained suggest an explanation of non-stoichiometric nature of neutralization of reactive oxygen species by derivatives of fullerenes, as well as provide new insight into the physical meaning of the work on the impact of nanoparticles at ultra-low concentrations on biological objects.


Assuntos
Fulerenos/química , Nanopartículas/química , Espécies Reativas de Oxigênio/química
7.
Org Biomol Chem ; 9(16): 5714-9, 2011 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-21713297

RESUMO

It has been revealed for the first time that sodium fullerenolate Na(4)[C(60)(OH)(∼30)] (NaFL), a water soluble polyhydroxylated [60]fullerene derivative, destroys amyloid fibrils of the Aß(1-42) peptide in the brain and prevents their formation in in vitro experiments. The cytotoxicity of NaFL was found to be negligibly low with respect to nine different culture cell lines. At the same time, NaFL showed a very low acute toxicity in vivo. The maximal tolerable dose (MTD) and LD50 for NaFL correspond to 1000 mg kg(-1) and 1800 mg kg(-1), respectively, as revealed by in vivo tests in mice using intraperitoneal drug injection. The observed pronounced anti-amyloid activity and low toxicity of NaFL make it a very promising lead drug for the development of potent fullerene-based therapeutic approaches for the treatment of amyloidoses, such as Alzheimer's disease and others.


Assuntos
Peptídeos beta-Amiloides/antagonistas & inibidores , Peptídeos beta-Amiloides/metabolismo , Fulerenos/química , Fulerenos/farmacologia , Fragmentos de Peptídeos/antagonistas & inibidores , Fragmentos de Peptídeos/metabolismo , Doença de Alzheimer/tratamento farmacológico , Amiloidose/tratamento farmacológico , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Fulerenos/toxicidade , Humanos , Camundongos
8.
Biofizika ; 54(2): 202-5, 2009.
Artigo em Russo | MEDLINE | ID: mdl-19402528

RESUMO

The inhibitory effect of hydrated fullerene C60 (HyFn) and the sodium salt of the fullerene polycarboxylic derivative C60Cl (C6H4CH2COONa)5 on the formation of amyloid fibrils by X-protein in vitro has been studied by electron microscopy. It has been shown that these compounds not only destroyed mature amyloid fibrils but also prevented the formation of new fibrils. This property of fullerenes, nanoparticles, can be used for the development of a novel medicinal nanotechnology in the therapy of amyloidoses.


Assuntos
Amiloide/química , Fulerenos/química , Proteínas Musculares/química , Nanopartículas/química , Amiloide/ultraestrutura , Animais , Nanopartículas/ultraestrutura , Coelhos
9.
J Chem Phys ; 128(16): 164715, 2008 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-18447487

RESUMO

The effect of a structure of a fullerene derivative on electronic properties of poly(3-hexylthiophene)/fullerene composite was studied at 3 cm wave band EPR in wide (77-320 K) temperature region. All the systems with different fullerene derivatives demonstrate sum spectrum of small polarons with different mobilities and contributions depending on the structure of the fullerene derivative. Both the spin-lattice and spin-spin relaxation times were determined separately by using the steady-state saturation method. The treatment of polymer matrix by fullerene derivative changes its dimensionality and conformation. This leads to the change in the spin relaxation and susceptibility as well as in the rate of polaron diffusion along polymer chain.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...